• Amprion secured a multi-million-dollar growth-funding investment from Decathlon Capital Partners to expand diagnostic testing capacity for neurodegenerative disorders.
• San Diego-based Amprion develops seed-amplification tests aimed at earlier, pathology-based diagnosis of diseases such as Parkinson’s and Lewy body dementia.
• Funding is positioned as non-dilutive, supporting global scaling of Amprion’s testing platform for clinicians and researchers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Decathlon Capital Partners LLC published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein.